Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

The Electron Transport Chain

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...

Antidotes

Antidotes

Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cellular and Molecular Effects of Targeting the CBP/β-Catenin Interaction with PRI-724 in Melanoma Cells, Drug-Naïve and Resistant to Inhibitors of BRAF<sup>V600</sup> and MEK1/2.

Cells·2025

Same author

Morphological alterations of peridroplet mitochondria in human liver biopsy.

Scientific reports·2025

Same author

Clinical examination performance in rural longitudinal medical programmes.

Education for primary care : an official publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors·2025

Same author

Synergistic activity of S63845 and parthenolide to overcome acquired resistance to MEK1/2 inhibitor in melanoma cells: Mechanisms and therapeutic potential.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025

Same author

Pathological significance of intranuclear structures in liver biopsy samples.

Hepatology research : the official journal of the Japan Society of Hepatology·2025

Same author

Artificial Intelligence vs. Human Cognition: A Comparative Analysis of ChatGPT and Candidates Sitting the European Board of Ophthalmology Diploma Examination.

Vision (Basel, Switzerland)·2025

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Use of Electron Paramagnetic Resonance in Biological Samples at Ambient Temperature and 77 K

Use of Electron Paramagnetic Resonance in Biological Samples at Ambient Temperature and 77 K

Published on: January 11, 2019

[Superoxide dismutase mimetics: possible clinical applications].

Michał Woźniak¹, Małgorzata Czyz

¹Zakład Biologii Molekularnej Nowotworów, Uniwersytet Medyczny, Łódź.

Postepy Higieny I Medycyny Doswiadczalnej (Online)

|November 13, 2008

Summary

This summary is machine-generated.

Reactive oxygen species contribute to aging and diseases. Synthetic superoxide dismutase enzyme mimetics offer a novel approach to protect healthy tissues during medical treatments.

More Related Videos

Measuring Trans-Plasma Membrane Electron Transport by C2C12 Myotubes

Measuring Trans-Plasma Membrane Electron Transport by C2C12 Myotubes

Published on: May 4, 2018

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

Related Experiment Videos

Last Updated: Jun 28, 2026

Use of Electron Paramagnetic Resonance in Biological Samples at Ambient Temperature and 77 K

Use of Electron Paramagnetic Resonance in Biological Samples at Ambient Temperature and 77 K

Published on: January 11, 2019

Measuring Trans-Plasma Membrane Electron Transport by C2C12 Myotubes

Measuring Trans-Plasma Membrane Electron Transport by C2C12 Myotubes

Published on: May 4, 2018

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

Area of Science:

Biochemistry
Pharmacology
Oxidative Stress Research

Context:

Reactive oxygen species (ROS), including superoxide, hydrogen peroxide, and peroxynitrite, are implicated in aging and various diseases like cancer, diabetes, inflammation, and neurodegenerative disorders.
Therapeutic interventions such as radiation therapy, chemotherapy, ischemia-reperfusion injury, and transplantation can elevate ROS levels, leading to significant organ damage.
Protecting normal tissues from ROS-induced damage without compromising therapeutic efficacy is a critical challenge in clinical practice.

Purpose:

To review synthetic low-molecular-weight catalytic antioxidants that act as superoxide dismutase enzyme mimetics (SODm).
To explore the potential of these SODm agents in treating diseases associated with oxidative stress.
To evaluate their utility in safeguarding healthy tissues during various medical treatments.

Summary:

This review discusses synthetic low-molecular-weight compounds designed as superoxide dismutase enzyme mimetics (SODm).
These agents are investigated for their capacity to neutralize harmful reactive oxygen species.
The focus is on their dual role in disease treatment and normal tissue protection during therapy.

Impact:

Potential for novel therapeutic strategies targeting age-related diseases and conditions linked to oxidative stress.
Development of adjunct therapies to mitigate side effects of treatments like chemotherapy and radiation.
Improved patient outcomes through enhanced protection of healthy tissues during critical medical interventions.